Vnitr Lek 2010, 56(Suppl 1):70-73

Monitoring of coagulation parameters and options to influence them in patients with liver cirrhosis prior to invasive procedures

P. Vychodil*, E. Kieslichová
Klinika anesteziologie, resuscitace a intenzivní péče IKEM Praha, přednostka prim. MUDr. Eva Kieslichová

For coagulation monitoring in cirrhotic patients it is sufficient to measure PT, aPTT, fibrinogen, platelets and to take history of antiaggregation therapy. In doubt, or in extensive untreatable bleeding, native thrombelastography and modified heparinase I thrombeastography measurement for detection of heparinoid influence is indicated. The most important for adjustment of the coagulation state is platelet concentrate preparation for thrombocytopenic patients and correction of PT close before procedure, or in the beginning of procedure if possible.

Keywords: liver cirrhosis; coagulation disorders; coagulation monitoring; thrombocytopenia; surgical procedure

Received: March 31, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vychodil P, Kieslichová E. Monitoring of coagulation parameters and options to influence them in patients with liver cirrhosis prior to invasive procedures. Vnitr Lek. 2010;56(Supplementum 1):70-73.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Špičák J. Novinky v gastroenterologii a hepatologii. Praha: Grada Publishing 2008.
    2. Colman RW. Hemostasis and Thrombosis. 5th ed. Philadelphia: Lippincott Williams & Wilkins 2006.
    3. Montalto P, Vlachogiannakos J, Cox DJ et al. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37: 463-470. Go to original source... Go to PubMed...
    4. Kerr R, Newsome P, Germain L et al. Effects of acute liver injury on blood coagulation. J Throm Hemost 2003; 4: 754-759. Go to original source... Go to PubMed...
    5. Adinolfi LE, Giordano MG, Andreana A et al. Hepatic fibrosis plays central role in the pathogenesis od thrombocytopenia in patient with chronic viral hepatitis. Br J Haematol 2001; 113: 590-595. Go to original source... Go to PubMed...
    6. Lisman T, Leebeek F, Mosnier L et al. Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis. Gastroenterology 2001; 121: 131-139. Go to original source... Go to PubMed...
    7. Mannucci PM, Franca F, Dioguardi N. Correction of abnormal coagulation in chronic liver disease by combined use of FFP and PCC. Lancet 1976; 308: 542-545. Go to original source... Go to PubMed...
    8. Rana R, Fernández-Pérez ER, Anjum Khan S et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion 2006; 46: 1478-1483. Go to original source... Go to PubMed...
    9. Tripodi A, Primignani M, Chantarangkul V. Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology 2006; 44: 440-445. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.